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Abstract
This study used tissue samples from male B6C3F1 mice treated with ethanol in drinking water (0,
2.5, or 5%) for 4 or 104 weeks. We tested whether chronic alcohol drinking promotes oxidative
stress in the liver and characterized the mutation profile of spontaneous and ethanol-induced
tumors. We show that ethanol does not cause detectable oxidative stress in the liver at any time
point and acts by promoting H-ras mutated cells.
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2. Introduction
Excessive consumption of alcoholic beverages is a major public health issue around the
world. According to the World Health Organization Global Burden of Disease Project,
alcohol drinking accounts for approximately 3.2% of all deaths and 3.6% of all cancers [1].
Since 1988, alcohol (ethanol) drinking has been classified as carcinogenic to humans
(Group 1) by the International Agency for Research on Cancer [2]. Evidence accumulated in
the past decade, especially the data on the carcinogenicity of ethanol in animals [3],
prompted the International Agency for Research on Cancer to re-evaluate alcoholic
beverages and classify “ethanol in alcoholic beverages” as carcinogenic to humans (Group
1) in 2007 [4].
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Alcohol consumption has been causally linked to the occurrence of malignant tumors of the
oral cavity, pharynx, larynx, esophagus, liver, colorectum, and female breast [4]. The
addition of breast cancer and colorectal cancer, two of the most common cancers worldwide,
to the list of ethanol-related cancers (4) suggests that the proportion of cancers attributable
to alcohol consumption is even higher than previously estimated. Liver is one of key target
organs for alcohol-associated disease in humans [5;6]. Liver pathological states that have
been causally linked to alcohol consumption include steato-hepatitis (characterized by early
steatosis, inflammation, and necrosis), fibrosis and cirrhosis, and hepatocellular carcinoma
[7]. With regard to liver tumors, ethanol was long considered to be a co-carcinogen as well
as a tumor promoter [8–11] since no experimental evidence was available to demonstrate
that ethanol administration alone was sufficient to induce tumors. Only recently have several
life-time studies with ethanol in drinking water showed an increased incidence of tumors in
the liver in both rats and mice [12–14].
The metabolism of ethanol plays a major role in tumor formation at multiple sites [7].
Ethanol is metabolized to acetaldehyde mainly by alcohol dehydrogenase, catalase and
cytochrome P450 2E1 (CYP2E1), followed by oxidation of acetaldehyde to acetate by
acetaldehyde dehydrogenase [15]. One of the major negative side-effects in this metabolic
pathway is associated with the ability of ethanol to induce CYP2E1, which is known to
generate reactive oxygen species [16] that may damage DNA, lipids, and proteins [7;17;18].
Additionally, acetaldehyde, recently classified as carcinogenic to humans when “associated
with consumption of alcoholic beverages” [19], reacts with DNA causing the formation of
N2-ethyl-2′-deoxyguanosine (after reduction of the Shiff’s base resulting from acetaldehyde)
and 1, N2-propano-2′-deoxyguanosine DNA adducts [20]. Only limited evidence exists from
human studies to confirm these or other modes of ethanol’s carcinogenic action [21;22].
Thus, animal studies where chronic administration of ethanol in drinking-water caused a
dose-related increase in the incidence of hepatocellular adenomas in male mice [3;12]
provides an important opportunity to understand better the mechanisms of alcohol-induced
liver carcinogenesis.
In this study we used normal liver tissue and, when available, liver tumors from male
B6C3F1 mice treated with ethanol in drinking water (0, 2.5, or 5%) for 4 or 104 weeks to
test whether alcohol drinking promotes oxidative stress in the liver and to characterize better
the genetic changes in spontaneous and ethanol-induced tumors. We demonstrate that
ethanol does not cause detectable oxidative stress in the liver at either time point. Most of
the adenomas and carcinomas observed in the mice from the 2-year study (regardless of
treatment with ethanol) were positive for H-ras and all were negative for Hnf1α mutations.
While most of the spontaneous adenomas and carcinomas exhibited β-catenin activation,
only a few adenomas (and all carcinomas) in ethanol-treated groups were positive. This
suggests that in addition to H-ras mutations, mechanisms other than β-catenin activation
may be involved in preferential formation of liver adenomas in ethanol-treated mice.
3. Material and Methods
3.1. Samples and study design
Formalin-fixed liver tissues (5 μm sections) were obtained from the archives of the National
Toxicology Program 2-year carcinogenicity and toxicity studies with ethanol [3]. Details on
animal treatment, necropsy, and histopathological findings were published elsewhere [3;12].
Tissue samples from male B6C3F1 mice that received 0%, 2.5%, or 5% ethanol in the
drinking water for 4 or 104 weeks (starting at 28 days of age) were used in this study. All
experimental protocols for the in life portion of this study were reviewed and approved by
the Animal Care and Use Committee at the National Center for Toxicological Research.
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Cell proliferation was determined by immunodetection of proliferating cell nuclear antigen
(PCNA). Formalin-fixed paraffin-embedded sections of liver tissues were deparaffinized in
xylene and rehydrated in graded alcohol series, and placed in phosphate -buffered saline
(PBS) with 0.1% Tween 20. Endogenous peroxidase activity was quenched for 10 min with
Peroxidase Blocking Reagent (Dako, Carpinteria, CA). Immunostaining was performed
using EnVision System HRP (Dako) with a primary monoclonal anti-PCNA antibody
(Dako, M0879) diluted (1:200) in PBS containing 1% bovine serum albumin and an
incubation overnight at 4°C. Slides were counterstained for 5 min with hematoxylin.
Quantitative analysis of immune-stained liver sections was performed by determining the
ratio of positive stained nuclei to total nuclei within 10 random fields at 400×.
The extent of oxidative DNA damage was evaluated using goat anti-8-oxodeoxyguanosine
(8-OH-dG) antibody (1:200, RDI division of Fitzgerald Industries International, Concord,
MA) as previously described [23]. Quantitative analysis of immune-stained liver sections
was performed by determining the ratio of positive stained nuclei to total nuclei within 5
random fields at 400×.
The expression of F4/80, tissue macrophage-specific receptor, in liver was evaluated using
immunostaining on deparaffinized and rehydrated liver sections incubated in proteinase K
(20 μg/ml, Roche Diagnostics, Mannheim, Germany) for 5 min and in Peroxidase Blocking
Reagent (Dako) for 10 min at room temperature. Primary rat anti-mouse F4/80 antibody
(1:200 dilution, 30 minutes at room temperature, Serotec, Raleigh, NC) and Vectastain Elite
ABC-Peroxidase Kit (Vector Labs, Burlingame, CA) were used following manufacturer’s
instructions. Slides were counterstained for 5 min with hematoxylin. Quantitative analysis of
the stained liver sections was performed using Image-Pro® Plus (Media Cybernetics, Silver
Spring, MD) software by determining the ratio of positively stained area to total area within
10 random fields at 200×.
3.3. Screening for H-ras codon 61 mutation
Tumors were identified in the formalin fixed and paraffin-embedded liver sections from 0%
and 5% ethanol groups and genomic DNA was isolated by digestion with proteinase K,
followed by phenol–chloroform extraction and ethanol precipitation as detailed elsewhere
[24]. H-ras codon 61 mutations were screened using enriched PCR analysis as reported by
Mitchell and Warshawsky [25]. Briefly, a primary PCR amplification of tumor DNA was
performed and the PCR products were digested with Bcl I restriction endonuclease. Digested
PCR products were subject to a secondary PCR amplification, followed by digestion with
Bcl I restriction endonuclease. The digested products were separated on an agarose gel by
electrophoresis and the mutant bands were sequenced.
3.4. Screening for β-catenin activation and Hnf1α inactivation mutations
Immunostaining was performed on 5 μm sections of formalin fixed, paraffin-embedded
liver. Sections were deparaffinized, rehydrated and antigen retrieval was conducted using
Target Retrieval Solution (Dako). Slides were microwaved (high power, 5 min, 2 cycles)
followed by cooling at room temperature for 20 min. Glutamate-ammonia ligase (glutamine
synthetase, Glul) immunodetection was performed using Vector M.O.M. Immunodetection
Peroxidase Kit (Vector Labs, Burlingame, CA), following manufacturer’s instructions and
mouse anti-glutamine synthetase antibody (BD Transduction Lab, BD, Franklin Lakes, NJ)
was diluted (1:200) in PBS containing 1% bovine serum albumin and incubation 30 min at
room temperature. Liver fatty acid binding protein 1 (Fabp1) immunodetection was
performed using a rabbit anti-Fabp1 antibody (Abcam, Cambridge, MA) as previously
described [26]. Tumors with homogeneous or heterogeneous glutamine synthetase-positive
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staining were considered to be β-catenin activated, while a lack of Fabp1 staining in tumor
tissues signified Hnf1α inactivation.
3.5. Statistical analyses
Statistical analyses were performed using GraphPad Prism5 software (GraphPad Software,
San Diego, CA). Qualitative variables were compared with each other in contingency tables
by using a Chi-square or Fisher’s exact test. Quantitative variables were expressed as mean
and standard deviation. The differences between quantitative variances were evaluated by
one-way analysis of variances since the variances were equal. Differences in mutation
frequency were evaluated using the methodology of Cariello et al [27].
4. Results
4.1. Ethanol effect on cell proliferation in mouse liver
It has been shown previously that sub-chronic (4 weeks) treatment of male B6C3F1 mice
with ethanol in drinking water had little effect on cell proliferation and apoptosis in the liver
[12]. We also assessed cell proliferation in animals treated with ethanol for 2 years and
observed no effect on PCNA staining in non-tumoral liver tissues (Table 1). However, as
expected, the number of positive-stained nuclei was markedly elevated in the tumor tissues
(data not shown).
4.2. Ethanol effect on liver oxidative DNA damage and inflammation
Treatment with large amounts of ethanol has been shown to cause oxidative stress in liver in
rodent models. Traditional models for acute or sub-chronic administration of ethanol in mice
or rats, such as liquid diet [28], intragastric intubation [29], oral gavage binges [30], or
drinking water [31], have been shown to promote oxidant production in the liver, albeit at
very high doses of ethanol. Conversely, sub-chronic administration of low ethanol doses
(3% v/v in drinking water) to rats has shown little effect on oxidative stress [32]. The
exocyclic DNA adducts, etheno-deoxyadenosine and etheno-deoxycytidine, known to arise
from alcohol-induced oxidative stress and lipid peroxidation [33], were not increased in
animals treated with up to 5% of ethanol in drinking water for 4 weeks [12]. To evaluate
further whether chronic ingestion of ethanol at low dose can lead to oxidative stress and
inflammation, we assessed the extent of oxidative DNA damage using 8-OH-dG
immunohistochemistry. Ethanol had no effect on the level of 8-OH-dG in nuclear DNA in
mice treated for either 4 or 104 weeks (Table 1). In addition, the number of mature
macrophages was assessed using F4/80, which indicated no significant differences in the
liver macrophage populations between the groups (Table 1).
4.3. Chronic ingestion of ethanol in drinking water leads to a dose-dependent increase in
the incidence of liver adenomas in male B6C3F1 mice
Histopathological evaluation and body weights of male B6C3F1 mice treated with ethanol in
drinking water for 104 weeks have been reported previously [3;12]. Ethanol had no
significant effect on the incidence of non-neoplastic liver lesions or body weight in male
mice; however, a significant dose-related increasing trend in liver neoplastic lesions
(combined hepatocellular adenomas and carcinomas) was observed [12]. Upon further
examination of the individual trends for adenomas and carcinomas (Table 2), we determined
that ethanol led to a significant dose-dependent increase in the incidence of hepatocellular
adenomas, while carcinoma incidence was not affected, as previously reported [3].
Importantly, the incidence of hepatocellular adenomas in the 5% ethanol group (39.6%) was
significantly elevated (p=0.02, Fisher’s exact test) by more than 2.5-fold compared to
incidence of adenomas arising spontaneously in the control group (15.2%).
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4.4. Molecular characterization of the mutation profile of mouse liver tumors
The evaluation of the frequency and spectra of mutations in tumor-related genes in
chemically-induced neoplasms is useful for determining whether the carcinogenic effect is
due to the chemical or a spontaneous event [34]. We examined several genes that have been
reported to contain mutations in liver tumors in mice and humans. H-ras and Catnb (β-
catenin) are frequently mutated in mouse liver tumors. Interestingly, we observed a high
frequency of H-ras mutations at codon 61 in both spontaneous (control group) and ethanol-
induced (5% ethanol) tumors (Table 3), with little difference between frequency of these
mutations in adenomas or carcinomas. Next, we compared the spectrum of codon 61 H-ras
mutations in spontaneous tumors and 5% ethanol-induced tumors. We identified the same 3
substitutions at codon 61 in each group (Figure 1). There was no significant difference
(p=0.87) between both spectra; however, we observed a trend for an increase in the number
of CAA to CTA transversions and a decrease of CAA to AAA transversions in the tumors
from the 5% ethanol group.
The activation of β-catenin in formalin-fixed tissue was assessed by immunostaining for one
of its target genes, Glul, (Figure 2, top panel). Almost all of the spontaneous tumors (both
adenomas and carcinomas) and ethanol-group carcinomas were positive for Glul; however,
the frequency of positive staining was lower in ethanol-treated animals when either all
tumors or adenomas were considered (Table 3).
In humans, hepatocellular adenomas frequently exhibit HNF1A inactivation mutations [35].
Since ethanol caused a significant increase in the incidence of adenomas, we also tested for
this mutation. All tested tumors, as well as non-tumoral liver tissue, were uniformly
positively stained for Fabp1 (Figure 2, bottom panel), a target of Hnf1α, suggesting there
was no loss of Hnf1α function (Table 3).
5. Discussion
The mode of carcinogenic action of ethanol in the liver is complex and includes multiple
molecular events that may lead to tumor initiation, promotion, and progression [7]. Ethanol
may act as a co-carcinogen and a tumor promoter; however, several recent experiments
performed in rodents that received alcohol in their drinking water for 2 years or longer
indicated that ethanol is a complete carcinogen [4;12–14]. While these studies provide
evidence for the carcinogenic potential of ethanol, additional research is needed to determine
what mechanisms of ethanol-induced liver injury, which have been gleaned largely from
studies with high doses and short-term exposures, may also be applicable to the outcomes of
chronic low-level experiments. In this study, we performed additional experiments by using
formalin-fixed tissues available from male B6C3F1 mice chronically exposed to ethanol in
drinking water [12].
While ethanol metabolism is known to induce oxidative stress, we observed little evidence
for oxidative stress in the liver. The level of 8-OH-dG adducts, a marker of DNA damage,
was not affected by 4 weeks or 2 years of exposure to ethanol, while it has been previously
reported to be increased in other studies in both rats or mice [36–39]. When enteral ethanol
was administered for 28 days to rats, using a much higher concentration of ethanol as
compared to this study, 8-OH-dG adducts were significantly elevated after ethanol [18].
Assunçao et al. [40] also observed an increase in the level of 8-OH-dG adducts in rats
exposed to ethanol in drinking water, but also with a much higher concentration of ethanol
(20%). Similarly to our observation, we reported previously that there was no increase in the
level of 1, N6-ethenodeoxyadenosine or N2-ethyldeoxguanosine (13), DNA adducts from
either acetaldehyde (i.e., N2-ethyldeoxguanosine) or lipid peroxidation (i.e, 1, N6-
ethenodeoxyadenosine) formed during the metabolism of ethanol. It is possible that the
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methods that were used in this study for detection of oxidative stress may not be sensitive
enough to discern a small, yet biologically important effect. A similar challenge exists with
other liver carcinogens [41]. Thus, a limitation of this study is in the availability of only
formalin-fixed tissue and it may be difficult to find a biomarker or assay with sufficient
sensitivity.
The induction of CYP2E1 and activation of Kupffer cells have been suggested as primary
sources of oxidants in the liver after ethanol exposure [5;6]. It was previously shown that
neither the total cytochrome P450 content, nor the activity of CYP2E1 was affected after 4
weeks of treatment with up to 5% of ethanol [12]. In the present study, there was no effect
of ethanol on the number of Kupffer cells after either 4 or 104 weeks of treatment,
suggesting that there is no liver inflammation in this model of ethanol carcinogenesis.
Finally, since there was no evidence for increased cell proliferation in non-tumoral liver
tissues, we posit that ethanol may act by promoting spontaneously initiated cells.
Lifetime carcinogenicity assays in experimental animals also provide an invaluable
opportunity to compare rodent tumor’s molecular profiles with human malignancies, such as
the mutation spectra for known tumor-related genes, thus allowing for a more complete
understanding of carcinogenesis in rodents and the potential for extrapolation to human risk.
In this regard, it has been reported that the frequency and spectra of ras mutations in
spontaneous and chemically induced neoplasms extend the knowledge base for
understanding the mechanisms of carcinogenesis [34]. Thus, we evaluated genetic
alterations in both spontaneous and ethanol-induced tumors to identify whether the spectrum
and/or frequency of the mutations can serve as indicators of a genotoxic or non-genotoxic
mechanism.
It has been demonstrated that genotoxic hepatocarcinogens frequently increase the incidence
of codon 61 of H-ras mutations in tumors, while the frequency is the same or decreased with
non-genotoxic hepatocarcinogens [42–44]. In our study, we observed a very high incidence
of codon 61 of H-ras mutations in both spontaneous and ethanol-induced tumors while the
percentage of mice with tumors, mainly hepatocellular adenomas, significantly increased
among mice exposed to ethanol. This observation is similar to that reported with methylene
chloride where chemical-induced liver tumors had an H-ras mutation profile at codon 61
similar to that of spontaneous tumors [45]. Moreover, it also has been shown in studies with
mice that genotoxic compounds have an effect on the distribution of base changes in codon
61 of H-ras mutations, while non-genotoxic compounds have no effect [46–48]. In the
present study, there was no significant shift in the frequency of different H-ras mutations in
ethanol-induced tumors compared to spontaneous tumors, suggesting that ethanol acted as a
promoter agent. Thus, the similarities in mutation profile for the H-ras gene between
spontaneous liver tumors and ethanol-induced ones suggest that ethanol may act in liver by
promoting cells with spontaneous DNA lesions.
We also observed a decrease of the incidence of Glul-positive (β-catenin activated)
hepatocellular adenomas but not carcinomas in ethanol-treated animals. Since incidence of
spontaneous ethanol-induced hepatocellular carcinomas was the same, this result indicates
that β-catenin activation is not required for ethanol tumorigenesis. These data further support
the effect of ethanol on preferential promotion of H-ras mutated hepatocellular adenomas
and that ethanol is acting through a non-genotoxic mechanism.
Interestingly, all tumors were positive for Fabp1 staining, suggesting that Hnf1α was still
functional and ethanol does not induce Hnf1α-mutated adenomas. Thus far, HNF1
inactivation has been found only in human hepatocellular adenomas and not in mice
[35;49;50]. In humans, hepatocellular adenomas are relatively rare and preferentially occur
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in women in association with use of oral contraceptives [51]. In addition, a recent analysis of
HNF1A mutations in human adenomas suggested that occurrence of HNF1A-mutated
adenomas may be the consequence of a genotoxic damage [52]. Data on H-ras mutations in
codon 61 and the lack of evidence for Hnf1a inactivation provide additional support to non-
genotoxic effect of ethanol.
In conclusion, while chronic exposure to up 5% ethanol in drinking water significantly
increased incidence of hepatocellular adenomas in male B6C3F1 mice, oxidative stress and
inflammation, pathological features associated with high-dose exposures to ethanol, were
not increased. We observed that ethanol exposure was significantly associated with H-ras-
mutated hepatocellular adenomas and decreased frequency of β-catenin activation
mutations, suggesting that increased incidence of tumors in ethanol-treated groups is most
likely due to a promotion of H-ras-mutated cells by mechanisms other than β-catenin
activation.
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Figure 1. Spectrum of codon 61 H-ras mutations in hepatic tumors from male B6C3F1 mice
Sub-types of codon 61 H-ras mutations were quantitated in spontaneous tumors arising in
animals receiving 0% (left panel) or 5% ethanol (right panel) for 2 years.
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Figure 2. Glutamine synthetase (Glul) and liver-fatty acid binding protein 1 (Fabp1) staining in
adenomas and non-tumorous liver tissue from male B6C3F1 mice
Top panel: Liver adenomas (large masses) were positively stained for Glul in many, but not
all (top right) animals. In non-tumoral tissues the positive staining is restricted to pericentral
hepatocytes. Original magnification: 100×. Bottom panel: Serial sections were stained for
Fabp1. Uniform staining is evident in both tumorous and non-tumorous tissues.
Jeannot et al. Page 12







































































































































































































































































































































































































































































Jeannot et al. Page 14
Table 2
Incidence of liver tumors (hepatocellular adenomas or carcinomas) in male B6C3F1 mice treated with ethanol
in drinking water for 104 weeks.







0% 12 (26.1)† 7 (15.2)† 7 (15.2) 46
2.5% 16 (34.0)† 12 (25.5)† 6 (10.6) 47
5% 25 (52.1)*† 19 (39.6) ‡† 7 (14.6) 48
*
An asterisk indicates a significant (p=0.01) difference compared to spontaneous incidence of any tumors in control (0% ethanol) group.
†
A dagger indicates a significant (p=0.03) dose-dependent increasing trend.
‡
A double dagger indicates a significant (p=0.01) difference as compared to incidence of hepatocellular adenomas in control (0% ethanol) group.
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Table 3
Mutation profile of liver tumors in male B6C3F1 mice treated with ethanol in drinking water for 104 weeks.
Ethanol dose All tumors Hepatocellular adenomas Hepatocellular carcinomas
H-ras-mutated tumors
0% 10/11 (91%) 5/5 (100%) 3/4 (75%)
5% 16/20 (80%) 11/13 (85%) 4/5 (80%)
Glul-positive (β-catenin activation) tumors
0% 13/14 (93%) 5/6 (83%) 8/8 (100%)
2.5% 5/11 (45%)* 0/6 (0%)* 5/5 (100%)
5% 10/21 (48%)* 5/15 (33%)† 5/6 (83%)
L-Fabp-negative (Hnf1α inactivation) tumors
0% 0/14 (0%) 0/6 (0%) 0/6 (0%)
2.5% 0/11 (0%) 0/6 (0%) 0/5 (0%)
5% 0/21 (0%) 0/15 (0%) 0/6 (0%)
*
An asterisk indicates a significant difference from 0% ethanol group (p<0.05, Fisher’s exact test) when the numbers of animals with/without
positive staining were compared within “all tumors” or “hepatocellular adenomas” categories.
†
A dagger indicates a marginally significant (p=0.055) difference from the corresponding 0% ethanol group.
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